FDA-Drug2026-07-29Class IICHEMICAL
Major Pharmaceuticals levothyroxine sodium tablets recalled for subpotent drug
LABEL MIX UPNationwide distribution
Major Pharmaceuticals levothyroxine tablets recalled for low potency
Major Pharmaceuticals levothyroxine sodium 50 mcg tablets in certain lots contain less active ingredient than labeled, meaning they may not work as intended. This affects specific lot numbers expiring in October 2026 that were distributed nationwide.
- Check your levothyroxine bottle for lot number N02200A, N02200B (bag), or N02200 (blister) with expiration date 10/2026.
- If you have affected tablets, contact your pharmacy or prescriber before stopping or replacing your medication.
- Do not stop taking levothyroxine without guidance — thyroid hormone replacement is critical for your health.
Hazard
Subpotent Drug
Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3559-0; NDC Blister: 0904-6950-61
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0708-2026More Major Pharmaceuticals recalls
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium 75 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine sodium 150 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium Tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine 75 mcg tablets recalled for subpotent drug
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium 125 mcg tablets recalled for subpotency
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief